Loading clinical trials...
Loading clinical trials...
A Comparison of Latanoprost (Xalatan) With Travoprost (Travatan) and Bimatoprost (Lumigan) in Patients With Elevated Intraocular Pressure. A Twelve-week, Masked Evaluator, Phase IV, Multicenter Study in the United States. (Xalatan vs Travatan vs Lumigan).
Conditions
Interventions
latanoprost 0.005% ophthalmic solution
Travoprost 004% sterile ophthalmic solution
+1 more
Locations
40
United States
Pfizer Investigational Site
Bellflower, California, United States
Pfizer Investigational Site
Inglewood, California, United States
Pfizer Investigational Site
San Diego, California, United States
Pfizer Investigational Site
San Diego, California, United States
Pfizer Investigational Site
San Francisco, California, United States
Pfizer Investigational Site
Gainesville, Florida, United States
Start Date
January 1, 2002
Primary Completion Date
August 1, 2002
Completion Date
August 1, 2002
Last Updated
February 2, 2021
NCT07539675
NCT06289491
NCT07496957
NCT04354545
NCT07455786
NCT07298356
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions